ArticleClinicoEconomics and outcomes research : CEOR2012

Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension.

Ola Granström et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.